Tirzepatide is sold as Mounjaro for T2D and Zepbound for obesity in the US, and the two brands grew 110% and 123% to $7.41 billion and $4.26 billion, respectively, in the last quarter of 2025, year-on-year
Repeat testing at 4-8 weeks helps assess individual response and tolerability before dose adjustment
We tailor every clients solutions to their specific situation, empowering them to be the happiest, healthiest version of themselves
--- Typical Subcut Protocol (Research Context) Based on available literature and community protocols: Dose: 0.52 mg subcutaneous, once daily Cycle: 48 weeks on, 24 weeks off Reconstitution: Bacteriostatic water (0.9% benzyl alcohol) stable for 46 weeks refrigerated Injection site: Abdomen or thigh, rotated Stacking: Compatible with MOTS-C, BPC-157, and growth hormone secretagogues no known interference Note: GHK-Cu at higher doses can cause a transient copper taste or mild nausea in some users
Focus on proteins, healthy fats, fiber-rich vegetables, and whole grains
BID, Two times a day